Listar por autor "Luño Fernández, Elisa"
Mostrando ítems 7-26 de 38
-
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome
Valcárcel Ferreiras, David; Ademà Llobet, Vera; Solé Ristol, Francesc; Luño Fernández, Elisa (American Society of Clinical Oncology, 2013) -
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.
Espinet, Blanca; Ferrer, A.; Bellosillo, B.; Nonell, L.; Luño Fernández, Elisa (American Association for Cancer Research, 2014) -
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry
Bernal del Castillo, Teresa; Martínez Camblor, Pablo; Sánchez García, Joaquín; Paz, Raquel de; Luño Fernández, Elisa; Nomdedeu, Benet; Ardanaz, María Teresa; Pedro, Carme; Amigo, M. L.; Xicoy, Blanca (Nature Publishing Group, 2015) -
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis
Hernández Boluda, Juan Carlos; Pereira, Arturo; Gómez, Montse; Boque, Concepción; Luño Fernández, Elisa (Ferrata Storti Foundation : The European Hematology Association, 2014) -
Monosomal karyotype in MDS : explaining the poor prognosis?
Schanz, J.; Tüchler, H.; Solé Ristol, Francesc; Luño Fernández, Elisa (Nature Publishing Group, 2013)